{
    "id": 31476,
    "fullName": "EGFR I744_K745delinsKIPVAI",
    "impact": "indel",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "EGFR I744_K745delinsKIPVAI results in a deletion of two amino acids in the protein kinase domain of the Egfr protein from aa 744 to 745, combined with the insertion of six amino acids at the same site (UniProt.org). I744_K745delinsKIPVAI has not been biochemically characterized, but is predicted to result in a gain of function based on the effect of other Egfr exon 19 insertions (PMID: 22190593).",
            "references": [
                {
                    "id": 439,
                    "pubMedId": 22190593,
                    "title": "EGFR exon 19 insertions: a new family of sensitizing EGFR mutations in lung adenocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22190593"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1956,
        "geneSymbol": "EGFR",
        "terms": [
            "EGFR",
            "ERBB",
            "ERBB1",
            "HER1",
            "mENA",
            "NISBD2",
            "PIG61"
        ]
    },
    "variant": "I744_K745delinsKIPVAI",
    "createDate": "11/05/2019",
    "updateDate": "11/05/2019",
    "referenceTranscriptCoordinates": {
        "id": 185266,
        "transcript": "NM_005228",
        "gDna": "chr7:g.55174767_55174772delinsAAGATCCCTGTAGCAATC",
        "cDna": "c.2230_2235delinsAAGATCCCTGTAGCAATC",
        "protein": "p.I744_K745delinsKIPVAI",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 19044,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, Tarceva (erlotinib) treatment resulted in a partial response lasted for 7 months in a patient with metastatic lung adenocarcinoma harboring EGFR amplification and EGFR I744_K745delinsKIPVAI (PMID: 21841502).",
            "molecularProfile": {
                "id": 33828,
                "profileName": "EGFR I744_K745delinsKIPVAI EGFR amp"
            },
            "therapy": {
                "id": 4,
                "therapyName": "Erlotinib",
                "synonyms": null
            },
            "indication": {
                "id": 3910,
                "name": "lung adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 16690,
                    "pubMedId": 21841502,
                    "title": "Activity of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring rare epidermal growth factor receptor mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21841502"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 33827,
            "profileName": "EGFR I744_K745delinsKIPVAI",
            "profileTreatmentApproaches": [
                {
                    "id": 19751,
                    "name": "EGFR Inhibitor 2nd gen",
                    "profileName": "EGFR I744_K745delinsKIPVAI"
                },
                {
                    "id": 19753,
                    "name": "HER inhibitor (Pan)",
                    "profileName": "EGFR I744_K745delinsKIPVAI"
                },
                {
                    "id": 19750,
                    "name": "EGFR Inhibitor 1st gen",
                    "profileName": "EGFR I744_K745delinsKIPVAI"
                },
                {
                    "id": 19752,
                    "name": "EGFR Inhibitor 3rd gen",
                    "profileName": "EGFR I744_K745delinsKIPVAI"
                },
                {
                    "id": 19749,
                    "name": "EGFR Inhibitor (Pan)",
                    "profileName": "EGFR I744_K745delinsKIPVAI"
                }
            ]
        },
        {
            "id": 33828,
            "profileName": "EGFR I744_K745delinsKIPVAI EGFR amp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 185266,
            "transcript": "NM_005228",
            "gDna": "chr7:g.55174767_55174772delinsAAGATCCCTGTAGCAATC",
            "cDna": "c.2230_2235delinsAAGATCCCTGTAGCAATC",
            "protein": "p.I744_K745delinsKIPVAI",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}